+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Rescue chemotherapy in testicular germ cell tumors

Rescue chemotherapy in testicular germ cell tumors

Archivos Espanoles de Urologia 53(6): 554-564

To review the different salvage chemotherapy regimens according to the prognostic factors based on the response to the different therapeutic alternatives. The conventional rescue chemotherapy regimens, as well as the role of surgery, new drugs and therapeutic modalities, particularly high dose second and third line chemotherapy, were reviewed. Germ cell testicular tumor is the paradigm of curable tumors of the adult. Whereas the cure rate for stage I tumors is higher than 98%, patients with advanced stage tumors have a lower cure rate. Approximately 10% of the patients with good-prognosis factors and 30%-50% of those with poor-prognosis factors show tumor progression or recurrence after first line chemotherapy using cisplatin-based combinations. Patients who have recurrence after first line chemotherapy have a 40% probability of achieving second complete remission with second line chemotherapy, but will be sustained in only 20% of the patients, although rare cases of advanced pure seminoma that recurred have shown a cure rate of 55% with second line chemotherapy. New strategies have been developed using new drugs such as taxanes or high doses of well-known chemotherapeutic agents with autologous hematopoietic rescue that have been utilized with success in patients with refractory germ cell testicular tumors. A global analysis of the patients treated with third line chemotherapy shows a sustained complete remission rate of 22%. However, this percentage can only be increased to up to 50% for patients with no adverse factors.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 047243577

Download citation: RISBibTeXText

PMID: 11002524

Related references

Synchronous bilateral testicular germ cell tumors of different histologic type. Pathogenetic and practical implications of bilaterality in testicular germ cell tumors. Cancer 68(5): 1082-1085, 1991

The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group. Seminars in Oncology 25(2 Suppl 4): 24-32; Discussion 45-8, 1998

Testicular microlithiasis, chemotherapy for stage I seminoma, and chemotherapy for advanced extragonadal germ cell tumors. Reviews in Urology 4(4): 200-202, 2006

Intensified chemotherapy with stem-cell rescue in germ-cell tumors. Annals of Oncology 23(4): 815-822, 2012

High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. New England Journal of Medicine 357(4): 340-348, 2007

Treatment of relapsed or refractory germ cell tumors with high does chemotherapy and autologous stem cell rescue. Onkologie 14(SUPPL 2): 14, 1991

The role of myeloablative chemotherapy with autologous hematopoietic cell rescue in central nervous system germ cell tumors. Pediatric Blood and Cancer 54(4): 644-646, 2010

An overview of high dose chemotherapy with autologous stem cell rescue for germ cell tumors in current practice. Journal of B.U.On. 22(2): 306-311, 2017

Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors. Journal of Clinical Oncology 35(10): 1036-1040, 2016

Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors. Journal of Clinical Oncology 25(3): 247-256, 2007

Fertility after chemotherapy and radiotherapy for testicular germ cell tumors. Journal of Andrology (Supplement): 167, May-June, 2001

Gynecomastia as a complication of chemotherapy for testicular germ cell tumors. Urology 48(6): 944-946, 1996

High-dose chemotherapy and autologous peripheral blood stem cell rescue in refractory or relapsed nonseminomatous germ cell tumors. Onkologie 18(SUPPL 2): 109, 1995

Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors. Journal of Clinical Oncology 22(10): 1934-1943, 2004

Unusually Located Stroke After Chemotherapy in Testicular Germ Cell Tumors. Journal of Investigative Medicine High Impact Case Reports 3(2): 2324709615590198, 2015